Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 430-010-4 | CAS number: 12160-44-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: dermal
Administrative data
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP compliant guideline study, available as unpublished report, no restrictions, fully adequate for assessment.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 997
- Report date:
- 1997
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.3 (Acute Toxicity (Dermal))
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
Test material
- Reference substance name:
- -
- EC Number:
- 430-010-4
- EC Name:
- -
- Cas Number:
- 12160-44-0
- Molecular formula:
- K2Fe22O34
- IUPAC Name:
- hydrate iron potassium hydride
- Details on test material:
- - Name of test material (as cited in study report):Potassium ferrite
- Physical state: Reddish brown powder
- Composition of test material, percentage of components: K2Fe22O34; 83,8%, K2Fe10O16; 6.2%, K2CO3 1.5H2O; 10.0%
- Lot/batch No.: 23388-17 CG20X 407448A
- Expiration date of the lot/batch: 6 August 1997
- Storage condition of test material: Room temperature, dark, desiccated
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan U.K. Ltd, Bicester, Oxon, England
- Age at study initiation: approx. 8 weeks
- Weight at study initiation: 228 grams
- Housing: metal cages with wire mesh floors
- Diet : standard laboratory rodent diet (RM 1 (E) SQC) available ad libitum
- Water: drinking water available ad libitum
- Acclimation period: 11 days prior to start study
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 18.5 - 22
- Humidity (%): 37-59
- Air changes (per hr): 10-15
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Type of coverage:
- occlusive
- Vehicle:
- corn oil
- Details on dermal exposure:
- TEST SUBSTANCE PREPARATION: Potassium ferrite was formulated at the maximum practical concentration of 83.33% w/v in corn oil and administered at a dose volume of 2.4 mL/kg bodyweight. The test material was prepared on the day of dosing. The absorption of the test substance was not determined.
ADMINISTRATION OF THE TEST SUBSTANCE: Due to the irritant nature of the test material only one female rat was treated (at 2000 mg/kg bodyweight). One day prior to treatment, hair was removed from the dorso-lumbar region of the rat with electric clippers taking care to avoid damaging the skin, exposing an area equivalent to approximately 10% of the total body surface area. The test substance was applied by spreading it evenly over the prepared skin. The treatment area (approximately 50 mm x 50 mm) was covered with porous gauze held in place with a non irritating dressing, and further covered by a waterproof dressing encircled firmly around the trunk of the animal. Treatment in this manner was performed on Day 1 (day of dosing) of the study only. At the end of the 24 hours exposure period the dressing was carefully removed and the treated area of skin was washed with warm water (30° to 40°C) to remove any residual test substance. The treated area was blotted dry with absorbent paper. - Duration of exposure:
- 24 hours
- Doses:
- 2000 mg/kg bw
- No. of animals per sex per dose:
- 1 female
- Control animals:
- no
- Details on study design:
- Due to the irritant nature of the test material only one female rat was treated (at 2000 mg/kg bodyweight)
- Duration of observation period following administration: 14 days
Frequency of observations and weighing:
- Mortality: The rat was checked at least twice daily for mortality.
- Clinical signs: After dosing and at frequent intervals for the remainder of Day 1. On subsequent days the animal was observed once in the moming and again at the end of the experimental day (with the exception of Day 15 - moming only). Consideration was given each day as to whether continuation of the study was justified. The latter observation each day was at approximately 16.30 hours on week days or 11.30 hours on Saturdays and Sundays. The nature and severity of the clinical signs and time were recorded at each observation.
- Dermal responses: Local dermal irritation at the treatment site was assessed.
- Bodyweights: The bodyweight of each rat was recorded on Days 1 (prior to dosing), 8 and 15. Weekly bodyweight changes were calculated.
- Macroscopic pathology: The animal was subjected to a macroscopic examination which consisted of opening the abdominal and thoracic cavities. The cranial cavity was not examined as observations did not indicate neurotoxic activity. The macroscopic appearance of all tissues was recorded and any macroscopic abnormalities were preserved.
Results and discussion
Effect levels
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Mortality:
- There was no death following a single dermal application of Potassium ferrite to one female rat at a dosage of 2000 mg/kg bodyweight.
- Clinical signs:
- other: There were no signs of systemic response in the animal throughout the study.
- Gross pathology:
- No macroscopic abnormalities were observed for the animal killed on Day 15.
- Other findings:
- A severe dermal response, characterised by necrosis/whitening of the epidermis and moderate oedema, was evident following removal of the dressings. A similar level of dermal response was persistent through the study, with some slight recovery evident by day 13.
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
